These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

80 related items for PubMed ID: 10801370

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. Benefits of antithrombotic therapy after infrainguinal bypass grafting: a meta-analysis.
    Collins TC, Souchek J, Beyth RJ.
    Am J Med; 2004 Jul 15; 117(2):93-9. PubMed ID: 15234644
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. Safety and efficacy evaluation of clopidogrel compared to ticlopidine after stent implantation: an updated meta-analysis.
    Casella G, Ottani F, Pavesi PC, Sangiorgio P, Rubboli A, Galvani M, Fontanelli A, Bracchetti D.
    Ital Heart J; 2003 Oct 15; 4(10):677-84. PubMed ID: 14664280
    [Abstract] [Full Text] [Related]

  • 5. The effects of oral anticoagulants in patients with peripheral arterial disease: rationale, design, and baseline characteristics of the Warfarin and Antiplatelet Vascular Evaluation (WAVE) trial, including a meta-analysis of trials.
    WAVE Investigators.
    Am Heart J; 2006 Jan 15; 151(1):1-9. PubMed ID: 16368284
    [Abstract] [Full Text] [Related]

  • 6. Antiplatelet therapy in peripheral occlusive arterial disease.
    Wong S, Appleberg M, Lewis DR.
    ANZ J Surg; 2006 May 15; 76(5):364-72. PubMed ID: 16768698
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. High prevalence of peripheral arterial disease and low treatment rates in elderly primary care patients with diabetes.
    Lange S, Diehm C, Darius H, Haberl R, Allenberg JR, Pittrow D, Schuster A, von Stritzky B, Tepohl G, Trampisch HJ.
    Exp Clin Endocrinol Diabetes; 2004 Nov 15; 112(10):566-73. PubMed ID: 15578331
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. [Conservative therapy of peripheral arterial occlusive disease].
    Frauchiger B.
    Schweiz Rundsch Med Prax; 1990 Dec 11; 79(50):1560-3. PubMed ID: 2270377
    [Abstract] [Full Text] [Related]

  • 13. Bleeding risks of combination vs. single antiplatelet therapy: a meta-analysis of 18 randomized trials comprising 129,314 patients.
    Serebruany VL, Malinin AI, Ferguson JJ, Vahabi J, Atar D, Hennekens CH.
    Fundam Clin Pharmacol; 2008 Jun 11; 22(3):315-21. PubMed ID: 18485150
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Pharmacotherapy before and after revascularization: anticoagulation, antiplatelet agents, and statins.
    Dagher NN, Modrall JG.
    Semin Vasc Surg; 2007 Mar 11; 20(1):10-4. PubMed ID: 17386359
    [Abstract] [Full Text] [Related]

  • 16. Antiplatelet therapy for vascular interventions.
    Comerota AJ, Thakur S.
    Perspect Vasc Surg Endovasc Ther; 2008 Mar 11; 20(1):28-35. PubMed ID: 18388025
    [Abstract] [Full Text] [Related]

  • 17. Collaborative overview of randomised trials of antiplatelet therapy--II: Maintenance of vascular graft or arterial patency by antiplatelet therapy. Antiplatelet Trialists' Collaboration.
    BMJ; 1994 Jan 15; 308(6922):159-68. PubMed ID: 8312766
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. [Value of vasoactive drugs in conservative therapy of peripheral arterial occlusive disease].
    Scheffler A, Rieger H.
    Z Arztl Fortbild Qualitatssich; 1999 Nov 15; 93(9):639-44. PubMed ID: 10666827
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 4.